$ECX
ECARX Holdings Inc. Stock $ecx

$ecx Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000162828024014607 Filed on April 03, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$1.869B	$4.666B	$3.557B
YoY Change	-47.46%	31.18%	28.0%
Cost Of Revenue	$1.437B	$3.396B	$372.1M
YoY Change	-44.01%	812.62%	-81.03%
Gross Profit	$431.6M	$1.270B	$143.6M
YoY Change	-56.42%	784.37%	-82.43%
Gross Profit Margin	23.1%	27.22%	4.04%
Selling, General & Admin	$260.8M	$885.7M	$183.7M
YoY Change	-78.78%	382.21%	-68.85%
% of Gross Profit	60.41%	69.74%	127.9%
Research & Development	$473.4M	$1.220B	$175.6M
YoY Change	-59.96%	594.85%	-85.48%
% of Gross Profit	109.68%	96.05%	122.25%
Depreciation & Amortization		$85.80M	$9.809M
YoY Change		774.7%	-84.91%
% of Gross Profit		6.76%	6.83%
Operating Expenses	$728.8M	$2.178B	$356.2M
YoY Change	-70.33%	511.32%	-80.2%
Operating Profit	-$297.2M	-$907.5M	-$212.6M
YoY Change	-79.73%	326.86%	-78.34%
Interest Expense	-$17.32M	-$124.7M	$7.414M
YoY Change	-88.56%	-1781.59%	-94.37%
% of Operating Profit
Other Income/Expense, Net	-$12.19M	$23.56M	$26.09M
YoY Change	-146.72%	-9.67%	94.89%
Pretax Income	-$326.7M	-$1.019B	-$1.520B
YoY Change	-78.5%	-32.96%	28.57%
Income Tax	-$3.943M	-$3.643M	$21.57M
% Of Pretax Income
Net Earnings	-$294.8M	-$940.2M	-$223.2M
YoY Change	-84.44%	321.27%	-81.08%
Net Earnings / Revenue	-15.77%	-20.15%	-6.27%
Basic Earnings Per Share		-$2.79	-$7.92
Diluted Earnings Per Share	-$0.87	-$2.79	-$1.15
COMMON SHARES
Basic Shares Outstanding		337.4M shares	239.3M
Diluted Shares Outstanding		337.4M shares	239.3M

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$699.0M	$699.0M	$737.4M
YoY Change	-5.2%	-5.2%	10269872.14%
Cash & Equivalents	561.1M cnies
Short-Term Investments	$137.9M	$137.9M
Other Short-Term Assets	$364.3M	$364.3M	$261.0M
YoY Change	1899.34%	39.56%	33003.76%
Inventory	$160.8M	$160.8M	$131.6M
Prepaid Expenses
Receivables	$1.936B	$1.936B	$1.094B
Other Receivables	$128.8M	$128.8M	$1.057B
Total Short-Term Assets	$3.289B	$3.289B	$3.281B
YoY Change	591.33%	0.23%	412230.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$246.0M	$246.0M	$203.8M
YoY Change	107.68%	20.72%	97.54%
Goodwill
YoY Change
Intangibles	$25.26M
YoY Change	374.9%
Long-Term Investments	$301.0M	$301.0M	$489.8M
YoY Change	-38.54%	-38.54%	-63.83%
Other Assets	$252.6M	$252.6M	$239.7M
YoY Change	6594.54%	5.36%	-20.13%
Total Long-Term Assets	$978.9M	$978.9M	$970.0M
YoY Change	596.09%	0.92%	223.18%
TOTAL ASSETS
Total Short-Term Assets	$3.289B	$3.289B	$3.281B
Total Long-Term Assets	$978.9M	$978.9M	$970.0M
Total Assets	$4.268B	$4.268B	$4.251B
YoY Change	592.42%	0.39%	1312.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.097B	$2.097B	$1.264B
YoY Change	1312.02%	65.87%	66.0%
Accrued Expenses	$649.7M	$347.3M	$379.5M
YoY Change	71.18%	-8.49%	74710.67%
Deferred Revenue
YoY Change
Short-Term Debt	$1.210B	$1.210B	$1.038B
YoY Change	859.23%	16.52%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.215B	$4.215B	$3.599B
YoY Change	707.78%	17.12%	685905.45%
LONG-TERM LIABILITIES
Long-Term Debt	$455.7M	$455.7M	$439.9M
YoY Change	3.6%	3.6%
Other Long-Term Liabilities	$430.9M	$430.9M	$388.9M
YoY Change	9577.14%	10.79%	1648.25%
Total Long-Term Liabilities	$886.6M	$886.6M	$828.8M
YoY Change	637.83%	6.97%	3625.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.215B	$4.215B	$3.599B
Total Long-Term Liabilities	$886.6M	$886.6M	$828.8M
Total Liabilities	$5.189B	$5.189B	$4.428B
YoY Change	708.23%	17.18%	19345.44%
SHAREHOLDERS EQUITY
Retained Earnings	-6.670B cnies
YoY Change	16.8%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$921.4M	-$921.4M	-$177.2M
YoY Change
Total Liabilities & Shareholders Equity	$4.268B	$4.268B	$4.251B
YoY Change	592.42%	0.39%	1312.65%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	-$294.8M	-$940.2M	-$223.2M
YoY Change	-84.44%	321.27%	-81.08%
Depreciation, Depletion And Amortization		$85.80M	$9.809M
YoY Change		774.7%	-84.91%
Cash From Operating Activities		-$1.243B	-$405.8M
YoY Change		206.44%	-53.48%
INVESTING ACTIVITIES
Capital Expenditures		$62.19M	$18.53M
YoY Change		235.71%	-76.51%
Acquisitions
YoY Change
Other Investing Activities		$654.3M	-$155.8M
YoY Change		-520.07%	-48.08%
Cash From Investing Activities		$592.1M	-$41.11M
YoY Change		-1540.31%	-97.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		296.8M	77.97M
YoY Change		280.7%	-96.44%
NET CHANGE
Cash From Operating Activities		-1.243B	-405.8M
Cash From Investing Activities		592.1M	-41.11M
Cash From Financing Activities		296.8M	77.97M
Net Change In Cash		-354.5M	-17.78M
YoY Change		1894.02%	-82.73%
FREE CASH FLOW
Cash From Operating Activities		-$1.243B	-$405.8M
Capital Expenditures		$62.19M	$18.53M
Free Cash Flow		-$1.306B	-$424.3M
YoY Change		207.71%	-55.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1018823000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-143498000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6861000	cny
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29065000	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3643000	cny
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001861974
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#FairValueAdjustmentOfWarrants
CY2023Q4	exc	Amount Of Competent Directors AmountOfCompetentDirectors	0.67
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41576
CY2023	dei	Entity Registrant Name EntityRegistrantName	ECARX Holdings Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	5/F, Building 1, Zhongteng Building
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	2121 Longteng Avenue
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Xuhui District, Shanghai
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	200232
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-513000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1176758000	cny
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	1186
CY2023	dei	Auditor Name AuditorName	KPMG Huazhen LLP
CY2023	dei	Auditor Location AuditorLocation	Shanghai, China
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	860472000	cny
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	561148000	cny
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79036000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	40957000	cny
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	27126000	cny
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3821000	usd
CY2022Q4	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossCurrent	0	cny
CY2023Q4	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossCurrent	137876000	cny
CY2023Q4	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossCurrent	19419000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	179143000	cny
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	54634000	cny
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	7695000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	182572000	cny
CY2023Q4	us-gaap	Inventory Net InventoryNet	160781000	cny
CY2023Q4	us-gaap	Inventory Net InventoryNet	22646000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	911729000	cny
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	74122000	cny
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	10440000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	424918000	cny
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	441483000	cny
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	62181000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3853333000	cny
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3288741000	cny
CY2023Q4	us-gaap	Assets Current AssetsCurrent	463210000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	353855000	cny
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	300987000	cny
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	42393000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139607000	cny
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	120785000	cny
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17012000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	44861000	cny
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	179341000	cny
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25260000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	99652000	cny
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	125205000	cny
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17635000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	877699000	cny
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	978903000	cny
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	137876000	usd
CY2022Q4	us-gaap	Assets Assets	4731032000	cny
CY2023Q4	us-gaap	Assets Assets	4267644000	cny
CY2023Q4	us-gaap	Assets Assets	601086000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	870000000	cny
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1200000000	cny
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	169016000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	168405000	cny
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	9959000	cny
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-43065000	cny
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6066000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-47898000	cny
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	152791000	cny
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9237000	cny
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1301000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1169897000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1578081000	cny
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1403000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	42843000	cny
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	35664000	cny
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5023000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31110000	cny
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	35123000	cny
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4947000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	785134000	cny
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	614540000	cny
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	86557000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	21610000	cny
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	15794000	cny
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2225000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3927441000	cny
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4215479000	cny
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	593738000	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	439869000	cny
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	455701000	cny
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	64184000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68768000	cny
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	107605000	cny
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15156000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	16544000	cny
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5141000	cny
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	724000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	30716000	cny
CY2023Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	90871000	cny
CY2023Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	12799000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	838047000	cny
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	886624000	cny
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	124879000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4765488000	cny
CY2023Q4	us-gaap	Liabilities Liabilities	5102103000	cny
CY2023Q4	us-gaap	Liabilities Liabilities	718617000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	cny
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	cny
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5919660000	cny
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6093685000	cny
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	858278000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5730180000	cny
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6670371000	cny
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-939502000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-385886000	cny
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-344734000	cny
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-48555000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-196396000	cny
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-921410000	cny
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-129778000	usd
CY2022Q4	us-gaap	Nonredeemable Noncontrolling Interest NonredeemableNoncontrollingInterest	161940000	cny
CY2023Q4	us-gaap	Nonredeemable Noncontrolling Interest NonredeemableNoncontrollingInterest	86951000	cny
CY2023Q4	us-gaap	Nonredeemable Noncontrolling Interest NonredeemableNoncontrollingInterest	12247000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-34456000	cny
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-834459000	cny
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-117531000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4731032000	cny
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4267644000	cny
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	601086000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2779063000	cny
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3561994000	cny
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4666147000	cny
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	657213000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1962000000	cny
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2568115000	cny
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3396118000	cny
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	478333000	usd
CY2021	us-gaap	Gross Profit GrossProfit	817063000	cny
CY2022	us-gaap	Gross Profit GrossProfit	993879000	cny
CY2023	us-gaap	Gross Profit GrossProfit	1270029000	cny
CY2023	us-gaap	Gross Profit GrossProfit	178880000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1209580000	cny
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1332800000	cny
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1264308000	cny
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	178074000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	607868000	cny
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1310207000	cny
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	928761000	cny
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	130813000	usd
CY2021	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	0	cny
CY2022	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	22846000	cny
CY2023	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	7078000	cny
CY2023	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	997000	usd
CY2021	exc	Other Operating Income Expense Miscellaneous Net OtherOperatingIncomeExpenseMiscellaneousNet	207000	cny
CY2022	exc	Other Operating Income Expense Miscellaneous Net OtherOperatingIncomeExpenseMiscellaneousNet	-1939000	cny
CY2023	exc	Other Operating Income Expense Miscellaneous Net OtherOperatingIncomeExpenseMiscellaneousNet	-1751000	cny
CY2023	exc	Other Operating Income Expense Miscellaneous Net OtherOperatingIncomeExpenseMiscellaneousNet	-247000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	1817241000	cny
CY2022	us-gaap	Operating Expenses OperatingExpenses	2622100000	cny
CY2023	us-gaap	Operating Expenses OperatingExpenses	2187742000	cny
CY2023	us-gaap	Operating Expenses OperatingExpenses	308137000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1000178000	cny
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1628221000	cny
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-917713000	cny
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-129257000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	13655000	cny
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	13820000	cny
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	30501000	cny
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	4296000	usd
CY2021	us-gaap	Interest Expense InterestExpense	131585000	cny
CY2022	us-gaap	Interest Expense InterestExpense	44543000	cny
CY2023	us-gaap	Interest Expense InterestExpense	79309000	cny
CY2023	us-gaap	Interest Expense InterestExpense	11170000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3891000	cny
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-71928000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1607146000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1015180000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-142985000	usd
CY2021	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-1997000	cny
CY2022	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-42518000	cny
CY2023	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-74989000	cny
CY2023	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-10562000	usd
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-806000	cny
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-464000	cny
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	cny
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1173955000	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1564164000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-940191000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-132423000	usd
CY2021	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-1306000	cny
CY2022	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-714000	cny
CY2023	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	0	cny
CY2023	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	0	usd
CY2021	exc	Net Income Loss Available To Parent NetIncomeLossAvailableToParent	-1175261000	cny
CY2022	exc	Net Income Loss Available To Parent NetIncomeLossAvailableToParent	-1564878000	cny
CY2023	exc	Net Income Loss Available To Parent NetIncomeLossAvailableToParent	-940191000	cny
CY2023	exc	Net Income Loss Available To Parent NetIncomeLossAvailableToParent	-132423000	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	243564000	cny
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	354878000	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1418825000	cny
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1919756000	cny
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-940191000	cny
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-132423000	usd
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.99
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.99
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.02
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.02
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.79
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.79
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	236691093	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	236691093	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	239296386	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	239296386	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	337407225	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	337407225	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	337407225	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	337407225	shares
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1176758000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1607146000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1015180000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-142985000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	0	cny
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	0	cny
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	0	cny
CY2023	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-1015180000	cny
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	174025000	cny
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	0	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	41152000	cny
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-834459000	cny
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4551000	cny
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-391934000	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	41152000	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	5796000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1172207000	cny
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1999080000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-974028000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-137189000	usd
CY2021	exc	Comprehensive Income Loss Net Of Tax Attributable To Non Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxAttributableToNonRedeemableNoncontrollingInterest	-1997000	cny
CY2022	exc	Comprehensive Income Loss Net Of Tax Attributable To Non Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxAttributableToNonRedeemableNoncontrollingInterest	-42518000	cny
CY2023	exc	Comprehensive Income Loss Net Of Tax Attributable To Non Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxAttributableToNonRedeemableNoncontrollingInterest	-74989000	cny
CY2023	exc	Comprehensive Income Loss Net Of Tax Attributable To Non Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxAttributableToNonRedeemableNoncontrollingInterest	-10562000	usd
CY2021	exc	Comprehensive Income Loss Net Of Tax Attributable To Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxAttributableToRedeemableNoncontrollingInterest	-806000	cny
CY2022	exc	Comprehensive Income Loss Net Of Tax Attributable To Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxAttributableToRedeemableNoncontrollingInterest	-464000	cny
CY2023	exc	Comprehensive Income Loss Net Of Tax Attributable To Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxAttributableToRedeemableNoncontrollingInterest	0	cny
CY2023	exc	Comprehensive Income Loss Net Of Tax Attributable To Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxAttributableToRedeemableNoncontrollingInterest	0	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1169404000	cny
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1956098000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-899039000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-126627000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2064043000	cny
CY2021	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-1175952000	cny
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	163481000	cny
CY2021	exc	Adjustments To Additional Paid In Capital Re Designation Of Ordinary Shares To Series Preferred Shares AdjustmentsToAdditionalPaidInCapitalReDesignationOfOrdinarySharesToSeriesPreferredShares	81208000	cny
CY2021	exc	Equity Method Investment Difference Between Carrying Amount And Consideration EquityMethodInvestmentDifferenceBetweenCarryingAmountAndConsideration	689670000	cny
CY2021	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	14335000	cny
CY2021	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-1306000	cny
CY2021	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	202000000	cny
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	cny
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	243564000	cny
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	0	cny
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	0	cny
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4551000	cny
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3900046000	cny
CY2021	exc	Net Income Loss After Tax Attributable To Non Redeemable Noncontrolling Interest NetIncomeLossAfterTaxAttributableToNonRedeemableNoncontrollingInterest	806000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3900046000	cny
CY2022	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-1606682000	cny
CY2022	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-714000	cny
CY2022	exc	Noncontrolling Interest Deconsolidation NoncontrollingInterestDeconsolidation	7178000	cny
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	725651000	cny
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	354878000	cny
CY2022	exc	Deemed Distribution From Restructuring Of Variable Interest Entity DeemedDistributionFromRestructuringOfVariableInterestEntity	61921000	cny
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	270539000	cny
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	69600000	cny
CY2022	exc	Stock Issued During Period Value Strategic Investment StockIssuedDuringPeriodValueStrategicInvestment	139200000	cny
CY2022	exc	Stock Issued During Period Value Share Exchange StockIssuedDuringPeriodValueShareExchange	87615000	cny
CY2022	exc	Stock Issued During Period Value Conversion Of Ordinary Shares StockIssuedDuringPeriodValueConversionOfOrdinaryShares	5492749000	cny
CY2022	exc	Issuance Of Ordinary Shares And Warrants Value To Shareholders And Warrant Holders IssuanceOfOrdinarySharesAndWarrantsValueToShareholdersAndWarrantHolders	30265000	cny
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	0	cny
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-391934000	cny
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-34456000	cny
CY2022	exc	Net Income Loss After Tax Attributable To Non Redeemable Noncontrolling Interest NetIncomeLossAfterTaxAttributableToNonRedeemableNoncontrollingInterest	464000	cny
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-34456000	cny
CY2021	us-gaap	Profit Loss ProfitLoss	-1176758000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-1607146000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-1015180000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-142985000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	cny
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6887000	cny
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7525000	cny
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1060000	usd
CY2021	exc	Provision Of Prepayments And Other Current Assets ProvisionOfPrepaymentsAndOtherCurrentAssets	3245000	cny
CY2022	exc	Provision Of Prepayments And Other Current Assets ProvisionOfPrepaymentsAndOtherCurrentAssets	-1935000	cny
CY2023	exc	Provision Of Prepayments And Other Current Assets ProvisionOfPrepaymentsAndOtherCurrentAssets	-1310000	cny
CY2023	exc	Provision Of Prepayments And Other Current Assets ProvisionOfPrepaymentsAndOtherCurrentAssets	-185000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	49485000	cny
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	35406000	cny
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	10641000	cny
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	1499000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	179933000	cny
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	725651000	cny
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	174025000	cny
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	24511000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65160000	cny
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	74559000	cny
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	85799000	cny
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12085000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	cny
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	41975000	cny
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	38842000	cny
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5471000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3891000	cny
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-71928000	cny
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-43065000	cny
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6066000	usd
CY2021	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	10579000	cny
CY2022	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	71974000	cny
CY2023	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	cny
CY2023	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	usd
CY2021	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	cny
CY2022	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	59728000	cny
CY2023	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	cny
CY2023	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	usd
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	cny
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-16843000	cny
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-22451000	cny
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-3162000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	99923000	cny
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	cny
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2863000	cny
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	403000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	111299000	cny
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3245000	cny
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-11719000	cny
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1651000	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1562000	cny
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1939000	cny
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1751000	cny
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-247000	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	12478000	cny
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1857000	cny
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2515000	cny
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-354000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	cny
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	cny
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10237000	cny
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1442000	usd
CY2021	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	19406000	cny
CY2022	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	41433000	cny
CY2023	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	-74509000	cny
CY2023	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	-10494000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	105557000	cny
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5341000	cny
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-11150000	cny
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1570000	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	5757000	cny
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	87080000	cny
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-34890000	cny
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-4915000	usd
CY2021	exc	Increase Decrease In Prepayments Of Other Current Assets IncreaseDecreaseInPrepaymentsOfOtherCurrentAssets	-157371000	cny
CY2022	exc	Increase Decrease In Prepayments Of Other Current Assets IncreaseDecreaseInPrepaymentsOfOtherCurrentAssets	-189669000	cny
CY2023	exc	Increase Decrease In Prepayments Of Other Current Assets IncreaseDecreaseInPrepaymentsOfOtherCurrentAssets	-17462000	cny
CY2023	exc	Increase Decrease In Prepayments Of Other Current Assets IncreaseDecreaseInPrepaymentsOfOtherCurrentAssets	-2459000	usd
CY2021	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-144529000	cny
CY2022	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	41101000	cny
CY2023	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-158446000	cny
CY2023	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-22317000	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	5253000	cny
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	3808000	cny
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-7179000	cny
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-1011000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	188317000	cny
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	204830000	cny
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-103334000	cny
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-14554000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	cny
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-34985000	cny
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-21545000	cny
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3035000	usd
CY2021	exc	Increase Decrease In Provisions IncreaseDecreaseInProvisions	8769000	cny
CY2022	exc	Increase Decrease In Provisions IncreaseDecreaseInProvisions	14424000	cny
CY2023	exc	Increase Decrease In Provisions IncreaseDecreaseInProvisions	60155000	cny
CY2023	exc	Increase Decrease In Provisions IncreaseDecreaseInProvisions	8473000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-907283000	cny
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-461337000	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1243406000	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-175129000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	85736000	cny
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	157286000	cny
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	62194000	cny
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8760000	usd
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	cny
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	1732000	cny
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	2158000	cny
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	304000	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1145637000	cny
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	79442000	cny
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	cny
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2021	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	cny
CY2022	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	cny
CY2023	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	163944000	cny
CY2023	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	23091000	usd
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	0	cny
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	0	cny
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	24000000	cny
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	3380000	usd
CY2021	exc	Proceeds On Deconsolidation Of Subsidiary ProceedsOnDeconsolidationOfSubsidiary	0	cny
CY2022	exc	Proceeds On Deconsolidation Of Subsidiary ProceedsOnDeconsolidationOfSubsidiary	1000000	cny
CY2023	exc	Proceeds On Deconsolidation Of Subsidiary ProceedsOnDeconsolidationOfSubsidiary	0	cny
CY2023	exc	Proceeds On Deconsolidation Of Subsidiary ProceedsOnDeconsolidationOfSubsidiary	0	usd
CY2021	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	0	cny
CY2022	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	28500000	cny
CY2023	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	0	cny
CY2023	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	0	usd
CY2021	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	48656000	cny
CY2022	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	57260000	cny
CY2023	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	214000000	cny
CY2023	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	30141000	usd
CY2021	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	90155000	cny
CY2022	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	29360000	cny
CY2023	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	214000000	cny
CY2023	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	30141000	usd
CY2021	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	0	cny
CY2022	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	0	cny
CY2023	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	792063000	cny
CY2023	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	111560000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1198234000	cny
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-313039000	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	592083000	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	83393000	usd
CY2021	exc	Proceeds From Redeemable Non Controlling Shareholders ProceedsFromRedeemableNonControllingShareholders	30000000	cny
CY2022	exc	Proceeds From Redeemable Non Controlling Shareholders ProceedsFromRedeemableNonControllingShareholders	10000000	cny
CY2023	exc	Proceeds From Redeemable Non Controlling Shareholders ProceedsFromRedeemableNonControllingShareholders	0	cny
CY2023	exc	Proceeds From Redeemable Non Controlling Shareholders ProceedsFromRedeemableNonControllingShareholders	0	usd
CY2021	exc	Proceeds From Non Redeemable Non Controlling Shareholders ProceedsFromNonRedeemableNonControllingShareholders	202000000	cny
CY2022	exc	Proceeds From Non Redeemable Non Controlling Shareholders ProceedsFromNonRedeemableNonControllingShareholders	0	cny
CY2023	exc	Proceeds From Non Redeemable Non Controlling Shareholders ProceedsFromNonRedeemableNonControllingShareholders	0	cny
CY2023	exc	Proceeds From Non Redeemable Non Controlling Shareholders ProceedsFromNonRedeemableNonControllingShareholders	0	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	947000000	cny
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1270000000	cny
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1500000000	cny
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	211271000	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	91000000	cny
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1332000000	cny
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1170000000	cny
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	164791000	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	cny
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	527281000	cny
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	cny
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	cny
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2938000	cny
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3396000	cny
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	478000	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	45152000	cny
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	700000000	cny
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	300000000	cny
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	42254000	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	65152000	cny
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	700000000	cny
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	300000000	cny
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	42254000	usd
CY2021	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	1125310000	cny
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	0	cny
CY2023	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	0	cny
CY2023	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	0	usd
CY2021	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	0	cny
CY2022	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	20000000	cny
CY2023	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	0	cny
CY2023	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	0	usd
CY2021	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0	cny
CY2022	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	43724000	cny
CY2023	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0	cny
CY2023	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0	usd
CY2021	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	0	cny
CY2022	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	139200000	cny
CY2023	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	0	cny
CY2023	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	0	usd
CY2021	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	cny
CY2022	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	136985000	cny
CY2023	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	78570000	cny
CY2023	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	11066000	usd
CY2021	exc	Proceeds From Conditional Government Grants ProceedsFromConditionalGovernmentGrants	0	cny
CY2022	exc	Proceeds From Conditional Government Grants ProceedsFromConditionalGovernmentGrants	0	cny
CY2023	exc	Proceeds From Conditional Government Grants ProceedsFromConditionalGovernmentGrants	48792000	cny
CY2023	exc	Proceeds From Conditional Government Grants ProceedsFromConditionalGovernmentGrants	6872000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2122792000	cny
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	657767000	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	296826000	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41808000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-32019000	cny
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28906000	cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41342000	cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5821000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14744000	cny
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-87703000	cny
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-313155000	cny
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-44107000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1003876000	cny
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	989132000	cny
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	901429000	cny
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126964000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	989132000	cny
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	901429000	cny
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	588274000	cny
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82857000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12557000	cny
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	cny
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1985000	cny
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	280000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	28983000	cny
CY2022	us-gaap	Interest Paid Net InterestPaidNet	28908000	cny
CY2023	us-gaap	Interest Paid Net InterestPaidNet	63859000	cny
CY2023	us-gaap	Interest Paid Net InterestPaidNet	8994000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	17882000	cny
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	24186000	cny
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	127595000	cny
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	17971000	usd
CY2021	exc	Bank Acceptance Notes Received To Settle Payable For Intangible Assets BankAcceptanceNotesReceivedToSettlePayableForIntangibleAssets	0	cny
CY2022	exc	Bank Acceptance Notes Received To Settle Payable For Intangible Assets BankAcceptanceNotesReceivedToSettlePayableForIntangibleAssets	0	cny
CY2023	exc	Bank Acceptance Notes Received To Settle Payable For Intangible Assets BankAcceptanceNotesReceivedToSettlePayableForIntangibleAssets	50000000	cny
CY2023	exc	Bank Acceptance Notes Received To Settle Payable For Intangible Assets BankAcceptanceNotesReceivedToSettlePayableForIntangibleAssets	7042000	usd
CY2021	exc	Non Cash Activities Of Re Designation Of Ordinary Shares To Series Preferred Shares NonCashActivitiesOfReDesignationOfOrdinarySharesToSeriesPreferredShares	97660000	cny
CY2022	exc	Non Cash Activities Of Re Designation Of Ordinary Shares To Series Preferred Shares NonCashActivitiesOfReDesignationOfOrdinarySharesToSeriesPreferredShares	0	cny
CY2023	exc	Non Cash Activities Of Re Designation Of Ordinary Shares To Series Preferred Shares NonCashActivitiesOfReDesignationOfOrdinarySharesToSeriesPreferredShares	0	cny
CY2023	exc	Non Cash Activities Of Re Designation Of Ordinary Shares To Series Preferred Shares NonCashActivitiesOfReDesignationOfOrdinarySharesToSeriesPreferredShares	0	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	620703000	cny
CY2022	us-gaap	Stock Issued1 StockIssued1	0	cny
CY2023	us-gaap	Stock Issued1 StockIssued1	0	cny
CY2023	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2021	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	cny
CY2022	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	247875000	cny
CY2023	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	cny
CY2023	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	usd
CY2021	us-gaap	Notes Issued1 NotesIssued1	0	cny
CY2022	us-gaap	Notes Issued1 NotesIssued1	5621000	cny
CY2023	us-gaap	Notes Issued1 NotesIssued1	0	cny
CY2023	us-gaap	Notes Issued1 NotesIssued1	0	usd
CY2021	exc	Non Cash Activities Of Amounts Due From Related Party For Sale NonCashActivitiesOfAmountsDueFromRelatedPartyForSale	0	cny
CY2022	exc	Non Cash Activities Of Amounts Due From Related Party For Sale NonCashActivitiesOfAmountsDueFromRelatedPartyForSale	763192000	cny
CY2023	exc	Non Cash Activities Of Amounts Due From Related Party For Sale NonCashActivitiesOfAmountsDueFromRelatedPartyForSale	0	cny
CY2023	exc	Non Cash Activities Of Amounts Due From Related Party For Sale NonCashActivitiesOfAmountsDueFromRelatedPartyForSale	0	usd
CY2021	exc	Issuance Of Ordinary Shares In Exchange For An Equity Security IssuanceOfOrdinarySharesInExchangeForAnEquitySecurity	0	cny
CY2022	exc	Issuance Of Ordinary Shares In Exchange For An Equity Security IssuanceOfOrdinarySharesInExchangeForAnEquitySecurity	87615000	cny
CY2023	exc	Issuance Of Ordinary Shares In Exchange For An Equity Security IssuanceOfOrdinarySharesInExchangeForAnEquitySecurity	0	cny
CY2023	exc	Issuance Of Ordinary Shares In Exchange For An Equity Security IssuanceOfOrdinarySharesInExchangeForAnEquitySecurity	0	usd
CY2021	exc	Payable For Costs Of Merger PayableForCostsOfMerger		cny
CY2022	exc	Payable For Costs Of Merger PayableForCostsOfMerger	133554000	cny
CY2023	exc	Payable For Costs Of Merger PayableForCostsOfMerger	0	cny
CY2023	exc	Payable For Costs Of Merger PayableForCostsOfMerger	0	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	cny
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	5492749000	cny
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	cny
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2021	exc	Conversion Of Convertible Notes Payable To Class A Ordinary Shares ConversionOfConvertibleNotesPayableToClassAOrdinaryShares	0	cny
CY2022	exc	Conversion Of Convertible Notes Payable To Class A Ordinary Shares ConversionOfConvertibleNotesPayableToClassAOrdinaryShares	69600000	cny
CY2023	exc	Conversion Of Convertible Notes Payable To Class A Ordinary Shares ConversionOfConvertibleNotesPayableToClassAOrdinaryShares	0	cny
CY2023	exc	Conversion Of Convertible Notes Payable To Class A Ordinary Shares ConversionOfConvertibleNotesPayableToClassAOrdinaryShares	0	usd
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	90724289	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	90724289	shares
CY2022Q4	exc	Redesignation Of Shares Number Of Common Shares For Each Preferred Share RedesignationOfSharesNumberOfCommonSharesForEachPreferredShare	1	shares
CY2022Q4	exc	Redesignation Of Shares Number Of Common Shares For Each Preferred Share RedesignationOfSharesNumberOfCommonSharesForEachPreferredShare	1	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000005
CY2022Q4	exc	Recapitalization Factor Per Share RecapitalizationFactorPerShare	1.19295710
CY2022Q4	exc	Recapitalization Factor Premoney Equity Value RecapitalizationFactorPremoneyEquityValue	3400000000	usd
CY2022Q4	exc	Recapitalization Factor Per Share Multiplier RecapitalizationFactorPerShareMultiplier	10.00
CY2022Q4	exc	Number Of Board Members To Elect NumberOfBoardMembersToElect	2	seat
CY2022Q2	exc	Number Of Equity Method Investments Transferred NumberOfEquityMethodInvestmentsTransferred	3	investment
CY2022Q2	exc	Number Of Investment And Consulting Companies NumberOfInvestmentAndConsultingCompanies	2	company
CY2022Q2	exc	Number Of Equity Method Investments Transferred NumberOfEquityMethodInvestmentsTransferred	3	investment
CY2022Q2	exc	Number Of Investment And Consulting Companies NumberOfInvestmentAndConsultingCompanies	2	company
CY2023Q2	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	1000	cny
CY2023	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	265667000	cny
CY2023Q2	exc	Business Combination Consideration Payable Period BusinessCombinationConsiderationPayablePeriod	P3Y
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6670371000	cny
CY2023Q4	exc	Net Current Assets Liabilities NetCurrentAssetsLiabilities	-926738000	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1243406000	cny
CY2023	us-gaap	Use Of Estimates UseOfEstimates	Use of estimatesThe preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, related disclosures of contingent assets and liabilities at the balance sheet date, and the reported revenues and expenses during the reported period in the consolidated financial statements and accompanying notes. Significant accounting estimates include, but not limited to, service period of connectivity services; expected credit losses for accounts receivable, other non-current assets and amounts due from related parties; realizability of inventories; accrual for warranty obligations; useful lives and recoverability of property, equipment and intangible assets and right-of-use assets; recoverability of long-term investments; valuation allowance of deferred tax assets; fair values of share-based compensation awards, redeemable convertible preferred shares, warrant liabilities, and incremental borrowing rates of the Group’s leases. Changes in facts and circumstances may result in these estimates to be revised. Actual results could differ from those estimates, and as such, differences may be material to the consolidated financial statements.
CY2023Q4	exc	Financing Receivable Term FinancingReceivableTerm	P6M
CY2021	us-gaap	Advertising Expense AdvertisingExpense	13674000	cny
CY2022	us-gaap	Advertising Expense AdvertisingExpense	11800000	cny
CY2023	us-gaap	Advertising Expense AdvertisingExpense	17651000	cny
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	168971000	cny
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	197669000	cny
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	213772000	cny
CY2023Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	7.0999
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	3240000	cny
CY2023Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	3240000	cny
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	3240000	cny
CY2023Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	3240000	cny
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Prior period reclassification <div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:109%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%"> The Group has reclassified certain prior period amounts as shown below to make the presentation consistent with current year. There was no change in total non-current liabilities and total liabilities as of December 31, 2022 and total operating expenses, loss from operation, loss before income taxes or net loss for the years ended December 31, 2021 and 2022 as a result of these reclassifications.</span></div>
CY2022Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	30716000	cny
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	cny
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	607868000	cny
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1310207000	cny
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-47898000	cny
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	152791000	cny
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	860472000	cny
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	561148000	cny
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	40957000	cny
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	27126000	cny
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	901429000	cny
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	588274000	cny
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	901429000	cny
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	588274000	cny
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	cny
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	cny
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6887000	cny
CY2021	exc	Accounts Receivable Allowance For Credit Loss Additions AccountsReceivableAllowanceForCreditLossAdditions	0	cny
CY2022	exc	Accounts Receivable Allowance For Credit Loss Additions AccountsReceivableAllowanceForCreditLossAdditions	6887000	cny
CY2023	exc	Accounts Receivable Allowance For Credit Loss Additions AccountsReceivableAllowanceForCreditLossAdditions	9951000	cny
CY2021	exc	Accounts Receivable Allowance For Credit Loss Reversal AccountsReceivableAllowanceForCreditLossReversal	0	cny
CY2022	exc	Accounts Receivable Allowance For Credit Loss Reversal AccountsReceivableAllowanceForCreditLossReversal	0	cny
CY2023	exc	Accounts Receivable Allowance For Credit Loss Reversal AccountsReceivableAllowanceForCreditLossReversal	2426000	cny
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	cny
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	cny
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	507000	cny
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	cny
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6887000	cny
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13905000	cny
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	65575000	cny
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	90882000	cny
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2999000	cny
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	11003000	cny
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	113998000	cny
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	58896000	cny
CY2022Q4	us-gaap	Inventory Net InventoryNet	182572000	cny
CY2023Q4	us-gaap	Inventory Net InventoryNet	160781000	cny
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	49485000	cny
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	35406000	cny
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	10641000	cny
CY2022Q4	us-gaap	Supplies Supplies	210819000	cny
CY2023Q4	us-gaap	Supplies Supplies	300890000	cny
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	192848000	cny
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	104309000	cny
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	21251000	cny
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	36284000	cny
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	424918000	cny
CY2023	us-gaap	Depreciation Depreciation	53959000	cny
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	7292000	cny
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	cny
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	103509000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	268469000	cny
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	441483000	cny
CY2022Q4	exc	Prepaid Expense And Other Assets Current Provision PrepaidExpenseAndOtherAssetsCurrentProvision	1310000	cny
CY2023Q4	exc	Prepaid Expense And Other Assets Current Provision PrepaidExpenseAndOtherAssetsCurrentProvision	0	cny
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	284536000	cny
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	252407000	cny
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	69319000	cny
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	48580000	cny
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	353855000	cny
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	300987000	cny
CY2022Q1	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	71974000	cny
CY2022	exc	Temporary Equity Redeemable Noncontrolling Interests Decrease From Deconsolidation TemporaryEquityRedeemableNoncontrollingInterestsDecreaseFromDeconsolidation	40750000	cny
CY2022Q4	exc	Nonredeemable Carrying Amount Noncontrolling Interest NonredeemableCarryingAmountNoncontrollingInterest	7178000	cny
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	cny
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	cny
CY2023	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	cny
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	cny
CY2022	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	cny
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	243443000	cny
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	276730000	cny
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	103836000	cny
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	148653000	cny
CY2022Q4	exc	Property Plant And Equipment Impairment Provision PropertyPlantAndEquipmentImpairmentProvision	0	cny
CY2023Q4	exc	Property Plant And Equipment Impairment Provision PropertyPlantAndEquipmentImpairmentProvision	7292000	cny
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139607000	cny
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	120785000	cny
CY2021	us-gaap	Depreciation Depreciation	43273000	cny
CY2022	us-gaap	Depreciation Depreciation	50527000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	58648000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	86183000	cny
CY2022Q4	exc	Intangible Assets Impaired Accumulated Impairment Loss IntangibleAssetsImpairedAccumulatedImpairmentLoss	0	cny
CY2023Q4	exc	Intangible Assets Impaired Accumulated Impairment Loss IntangibleAssetsImpairedAccumulatedImpairmentLoss	2945000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	44861000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	179341000	cny
CY2023Q4	exc	Software Licensing Agreement Period SoftwareLicensingAgreementPeriod	P3Y
CY2023Q4	exc	Software Licensing Agreement Period SoftwareLicensingAgreementPeriod	P3Y
CY2023Q4	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	50000000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P3Y
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21887000	cny
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24032000	cny
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	31840000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	68895000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	62511000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	46802000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	811000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	253000	cny
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2945000	cny
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	cny
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	cny
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	603523000	cny
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	341633000	cny
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	159371000	cny
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	364004000	cny
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	321215000	cny
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	603523000	cny
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	341633000	cny
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	207638000	cny
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	96651000	cny
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	36835000	cny
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	322000	cny
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	187000	cny
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-191569000	cny
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	246189000	cny
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	257207000	cny
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	103067000	cny
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	101487000	cny
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	61432000	cny
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	41924000	cny
CY2022Q4	exc	Accrued Costs Of Merger Current AccruedCostsOfMergerCurrent	136756000	cny
CY2023Q4	exc	Accrued Costs Of Merger Current AccruedCostsOfMergerCurrent	54984000	cny
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	237690000	cny
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	158938000	cny
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	785134000	cny
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	614540000	cny
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1225000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	247411000	cny
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	240647000	cny
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	95108000	cny
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	42094000	cny
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46250000	cny
CY2022Q4	exc	Operating Lease Right Of Use Asset Before Accumulated Depreciation OperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciation	141627000	cny
CY2023Q4	exc	Operating Lease Right Of Use Asset Before Accumulated Depreciation OperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciation	172643000	cny
CY2022Q4	exc	Operating Lease Right Of Use Asset Accumulated Depreciation OperatingLeaseRightOfUseAssetAccumulatedDepreciation	41975000	cny
CY2023Q4	exc	Operating Lease Right Of Use Asset Accumulated Depreciation OperatingLeaseRightOfUseAssetAccumulatedDepreciation	47438000	cny
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	99652000	cny
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	125205000	cny
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	47163000	cny
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	47828000	cny
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4234000	cny
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3675000	cny
CY2022	us-gaap	Lease Cost LeaseCost	51397000	cny
CY2023	us-gaap	Lease Cost LeaseCost	51503000	cny
CY2022	us-gaap	Lease Cost LeaseCost	51397000	cny
CY2023	us-gaap	Lease Cost LeaseCost	51503000	cny
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M4D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M20D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0670
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0865
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	35632000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	34332000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	24028000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	18396000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	18396000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	58616000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	189400000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	46672000	cny
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	142728000	cny
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	35123000	cny
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	107605000	cny
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	40173000	cny
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	31218000	cny
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	51621000	cny
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	56098000	cny
CY2020Q4	exc	Temporary Equity Carrying Amount Attributable To Parent With Subscription Receivable TemporaryEquityCarryingAmountAttributableToParentWithSubscriptionReceivable	232475000	cny
CY2021	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	3002374000	cny
CY2021	exc	Temporary Equity Issuance Cost TemporaryEquityIssuanceCost	-10000000	cny
CY2021	exc	Re Designation Of Ordinary Shares Into Preferred Shares Value ReDesignationOfOrdinarySharesIntoPreferredSharesValue	97660000	cny
CY2021	exc	Temporary Equity Subscription Contributions From Shareholder TemporaryEquitySubscriptionContributionsFromShareholder	1032104000	cny
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	243564000	cny
CY2021	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-65270000	cny
CY2021Q4	exc	Temporary Equity Carrying Amount Attributable To Parent With Subscription Receivable TemporaryEquityCarryingAmountAttributableToParentWithSubscriptionReceivable	4532907000	cny
CY2023	exc	Temporary Equity Subscription Contributions From Shareholder TemporaryEquitySubscriptionContributionsFromShareholder	159485000	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	354878000	cny
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	445479000	cny
CY2023	exc	Temporary Equity Value Conversion As Part Of Recapitalization TemporaryEquityValueConversionAsPartOfRecapitalization	5492749000	cny
	exc	Number Of Investors NumberOfInvestors	2	investor
CY2023	exc	Number Of Days Within Which Material Breach Is To Be Cured NumberOfDaysWithinWhichMaterialBreachIsToBeCured	30	day
CY2023	exc	Number Of Days Within Which Material Illegal Act Is To Be Cured NumberOfDaysWithinWhichMaterialIllegalActIsToBeCured	30	day
CY2023	exc	Number Of Days After Resignation Of Mr.Ziyu Shen To Appoint Successor NumberOfDaysAfterResignationOfMr.ZiyuShenToAppointSuccessor	30	day
CY2023	exc	Temporary Equity Redemption Price Percentage TemporaryEquityRedemptionPricePercentage	1
CY2023	exc	Temporary Equity Interest Rate Percentage TemporaryEquityInterestRatePercentage	0.08
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1
CY2023Q4	exc	Temporary Equity Liquidation Preference Percentage TemporaryEquityLiquidationPreferencePercentage	100
CY2023Q4	exc	Common Stock Liquidation Preference Percentage CommonStockLiquidationPreferencePercentage	100
CY2021Q3	exc	Minority Interest Ownership Percentage By Noncontrolling Owner MinorityInterestOwnershipPercentageByNoncontrollingOwner	0.02
CY2021Q3	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	1000000	cny
CY2021Q3	exc	Percentage Of Redeemable Noncontrolling Interest Per Annum PercentageOfRedeemableNoncontrollingInterestPerAnnum	0.49
CY2021Q3	us-gaap	Nonredeemable Noncontrolling Interest NonredeemableNoncontrollingInterest	14335000	cny
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	30500000	cny
CY2022	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	10000000	cny
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	464000	cny
CY2022	us-gaap	Temporary Equity Accretion Of Interest TemporaryEquityAccretionOfInterest	714000	cny
CY2022	exc	Temporary Equity Redeemable Noncontrolling Interests Decrease From Deconsolidation TemporaryEquityRedeemableNoncontrollingInterestsDecreaseFromDeconsolidation	40750000	cny
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	cny
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	cny
CY2021Q4	exc	Number Of Members In Management Group NumberOfMembersInManagementGroup	4	member
CY2023Q4	us-gaap	Treasury Stock Carrying Basis TreasuryStockCarryingBasis	1000	cny
CY2021Q4	exc	Number Of Shareholders NumberOfShareholders	4	company
CY2023	exc	Stockholders Equity Value Authorized Shares StockholdersEquityValueAuthorizedShares	50000000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	18995595	shares
CY2021Q4	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice	0.23
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.10
CY2022	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options New Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNewGrantsInPeriod	6680560	shares
CY2022	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options New Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNewGrantsInPeriodWeightedAverageExercisePrice	0.56
CY2022	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options New Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNewGrantsInPeriodWeightedAverageGrantDateFairValue	6.92
CY2022	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementGrantsInPeriod	3419811	shares
CY2022	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementGrantsInPeriodWeightedAverageExercisePrice	0.13
CY2022	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementGrantsInPeriodWeightedAverageGrantDateFairValue	1.47
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1244394	shares
CY2022	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice	0.54
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.97
CY2022	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replaced In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacedInPeriod	3419811	shares
CY2022	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementInPeriodWeightedAverageExercisePrice	1.24
CY2022	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementInPeriodWeightedAverageGrantDateFairValue	1.47
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	24431761	shares
CY2022Q4	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice	0.15
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.60
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options New Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNewGrantsInPeriod	4803035	shares
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options New Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNewGrantsInPeriodWeightedAverageExercisePrice	1.98
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options New Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNewGrantsInPeriodWeightedAverageGrantDateFairValue	1.65
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementGrantsInPeriod	4175352	shares
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementGrantsInPeriodWeightedAverageExercisePrice	0.21
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementGrantsInPeriodWeightedAverageGrantDateFairValue	4.88
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1336110	shares
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice	0.29
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	5.13
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replaced In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacedInPeriod	4175352	shares
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementInPeriodWeightedAverageExercisePrice	0.63
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementInPeriodWeightedAverageGrantDateFairValue	4.11
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12864832	shares
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice	0.05
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	15033854	shares
CY2023Q4	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice	0.69
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.91
CY2023Q4	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingNumber	15033854	shares
CY2023Q4	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestWeightedAverageExercisePrice	0.69
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestWeightedAverageGrantDateFairValue	4.91
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms	P8Y7M28D
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested And Expected To Vest ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedAndExpectedToVest	60132000	usd
CY2023Q4	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestExercisableNumber	13571754	shares
CY2023Q4	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	0.42
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantDateFairValue	5.36
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms	P8Y6M10D
CY2023	exc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable	60959000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	56876000	cny
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2779063000	cny
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3561994000	cny
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4666147000	cny
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2779063000	cny
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3561994000	cny
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4666147000	cny
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	cny
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-16843000	cny
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-22451000	cny
CY2021	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	cny
CY2022	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	59728000	cny
CY2023	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	cny
CY2021	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	10579000	cny
CY2022	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	71974000	cny
CY2023	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	cny
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	111299000	cny
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3245000	cny
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-11719000	cny
CY2021	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	34507000	cny
CY2022	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	59393000	cny
CY2023	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	11844000	cny
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	18315000	cny
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-18216000	cny
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10349000	cny
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-47898000	cny
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	152791000	cny
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9237000	cny
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1169897000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1578081000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1018823000	cny
CY2023	exc	Withholding Tax Rate WithholdingTaxRate	0.10
CY2022Q4	exc	Deferred Tax Liability Accrued For Dividend Withholding Taxes DeferredTaxLiabilityAccruedForDividendWithholdingTaxes	0	cny
CY2023Q4	exc	Deferred Tax Liability Accrued For Dividend Withholding Taxes DeferredTaxLiabilityAccruedForDividendWithholdingTaxes	0	cny
CY2021Q4	exc	Deferred Tax Liability Accrued For Dividend Withholding Taxes DeferredTaxLiabilityAccruedForDividendWithholdingTaxes	0	cny
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6861000	cny
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	29065000	cny
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-3529000	cny
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	cny
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	cny
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-114000	cny
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6861000	cny
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29065000	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3643000	cny
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2021	exc	Effective Income Tax Rate Reconciliation Preferential Tax Percent EffectiveIncomeTaxRateReconciliationPreferentialTaxPercent	0.10
CY2022	exc	Effective Income Tax Rate Reconciliation Preferential Tax Percent EffectiveIncomeTaxRateReconciliationPreferentialTaxPercent	-0.17
CY2023	exc	Effective Income Tax Rate Reconciliation Preferential Tax Percent EffectiveIncomeTaxRateReconciliationPreferentialTaxPercent	0.04
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.01
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.02
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.02
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.18
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.02
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.05
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.40
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.04
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.06
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.05
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.06
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.17
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.07
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.05
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.02
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	7654000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	3006000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2049000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2089000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	268381000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	218328000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1093000	usd
CY2022Q4	exc	Deferred Tax Asset Contract Cost Assets DeferredTaxAssetContractCostAssets	0	usd
CY2023Q4	exc	Deferred Tax Asset Contract Cost Assets DeferredTaxAssetContractCostAssets	6966000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	23037000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	19883000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	10961000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2360000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	14494000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	20340000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	7326000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	0	cny
CY2022Q4	exc	Deferred Tax Assets Donation DeferredTaxAssetsDonation	503000	cny
CY2023Q4	exc	Deferred Tax Assets Donation DeferredTaxAssetsDonation	302000	cny
CY2022Q4	exc	Deferred Tax Assets Government Grants DeferredTaxAssetsGovernmentGrants	0	cny
CY2023Q4	exc	Deferred Tax Assets Government Grants DeferredTaxAssetsGovernmentGrants	12198000	cny
CY2022Q4	exc	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	22781000	cny
CY2023Q4	exc	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	26634000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	201812000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	303198000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	558998000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	616397000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	537172000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	582644000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	21826000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	33753000	cny
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	21826000	cny
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	23904000	cny
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	cny
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1580000	cny
CY2022Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	0	cny
CY2023Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	8151000	cny
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	21826000	cny
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	33635000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	cny
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	118000	cny
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	362371000	cny
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	550520000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	537172000	cny
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	188149000	cny
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	121245000	cny
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	45472000	cny
CY2021	exc	Valuation Allowance Deferred Tax Asset Decrease For Reversal Of Net Operating Loss Carryforwards Due To Restructuring Amount ValuationAllowanceDeferredTaxAssetDecreaseForReversalOfNetOperatingLossCarryforwardsDueToRestructuringAmount	0	cny
CY2022	exc	Valuation Allowance Deferred Tax Asset Decrease For Reversal Of Net Operating Loss Carryforwards Due To Restructuring Amount ValuationAllowanceDeferredTaxAssetDecreaseForReversalOfNetOperatingLossCarryforwardsDueToRestructuringAmount	134593000	cny
CY2023	exc	Valuation Allowance Deferred Tax Asset Decrease For Reversal Of Net Operating Loss Carryforwards Due To Restructuring Amount ValuationAllowanceDeferredTaxAssetDecreaseForReversalOfNetOperatingLossCarryforwardsDueToRestructuringAmount	0	cny
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	550520000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	537172000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	582644000	cny
CY2021	exc	Net Income Loss Available To Parent NetIncomeLossAvailableToParent	-1175261000	cny
CY2022	exc	Net Income Loss Available To Parent NetIncomeLossAvailableToParent	-1564878000	cny
CY2023	exc	Net Income Loss Available To Parent NetIncomeLossAvailableToParent	-940191000	cny
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	243564000	cny
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	354878000	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	cny
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1418825000	cny
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1919756000	cny
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-940191000	cny
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	236691093	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	236691093	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	239296386	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	239296386	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	337407225	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	337407225	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.99
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.99
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.02
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.02
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.79
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.79
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	85354000	cny
CY2023Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	72021000	cny
CY2023Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	6667000	cny
CY2023Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	6667000	cny
CY2023Q4	us-gaap	Purchase Obligation Due In Fourth And Fifth Year PurchaseObligationDueInFourthAndFifthYear	0	cny
CY2023Q4	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	0	cny
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	39504000	cny
CY2023Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	38502000	cny
CY2023Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	1002000	cny
CY2023Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	0	cny
CY2023Q4	us-gaap	Contractual Obligation Due In Fourth And Fifth Year ContractualObligationDueInFourthAndFifthYear	0	cny
CY2023Q4	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	0	cny

Files In Submission

Name	View Source	Status
0001628280-24-014607-index-headers.html	Edgar Link	pending
0001628280-24-014607-index.html	Edgar Link	pending
0001628280-24-014607.txt	Edgar Link	pending
0001628280-24-014607-xbrl.zip	Edgar Link	pending
ecx-20231231xex429.htm	Edgar Link	pending
ecx-20231231xexx121.htm	Edgar Link	pending
ecx-20231231xexx122.htm	Edgar Link	pending
ecx-20231231xexx131.htm	Edgar Link	pending
ecx-20231231xexx132.htm	Edgar Link	pending
ecx-20231231xexx151.htm	Edgar Link	pending
ecx-20231231xexx152.htm	Edgar Link	pending
ecx-20231231xexx153.htm	Edgar Link	pending
ecx-20231231xexx428.htm	Edgar Link	pending
ecx-20231231xexx430.htm	Edgar Link	pending
ecx-20231231xexx431.htm	Edgar Link	pending
ecx-20231231xexx81.htm	Edgar Link	pending
ecx-20231231xexx971.htm	Edgar Link	pending
exc-20231231.htm	Edgar Link	pending
exc-20231231.xsd	Edgar Link	pending
exc-20231231_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
exc-20231231_def.xml	Edgar Link	unprocessable
exc-20231231_lab.xml	Edgar Link	unprocessable
exc-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
exc-20231231_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R138.htm	Edgar Link	pending
R139.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R140.htm	Edgar Link	pending
R141.htm	Edgar Link	pending
R142.htm	Edgar Link	pending
R143.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
exc-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ECX
ECARX Holdings Inc. Stock $ecx

2023 Q4 Form 20-F Financial Statement

#000162828024014607 Filed on April 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ECX ECARX Holdings Inc. Stock $ecx

2023 Q4 Form 20-F Financial Statement

#000162828024014607 Filed on April 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ECX
ECARX Holdings Inc. Stock $ecx